Mariyo Rokutan‐Kurata

Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma

Mariyo Rokutan‐Kurata, Akihiko Yoshizawa, Kentaro Ueno et al. · Journal of Thoracic Oncology · 2021 · 108 citations · Full text

Medicine, Oncology, Pathology +17

Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases

Mariyo Rokutan‐Kurata, Akihiko Yoshizawa, Shinji Sumiyoshi et al. · Clinical Lung Cancer · 2016 · 30 citations

Medicine, Molecular Biology, Oncology +10

<scp>GATA</scp>6‐positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and <i><scp>KRAS</scp></i> mutations

Naoki Nakajima, Akihiko Yoshizawa, Tomoyuki Nakajima et al. · Histopathology · 2018 · 26 citations · Full text

Medicine, Oncology, Pathology +16

Evaluating the effectiveness of <scp>RNA </scp><i>in‐situ</i> hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement

Naoki Nakajima, Akihiko Yoshizawa, Kyoko Kondo et al. · Histopathology · 2017 · 16 citations

Medicine, Oncology, Pathology +17

Discohesive growth pattern (Disco-p) as an unfavorable prognostic factor in lung adenocarcinoma: an analysis of 1062 Japanese patients with resected lung adenocarcinoma

Mariyo Rokutan‐Kurata, Akihiko Yoshizawa, Naoki Nakajima et al. · Modern Pathology · 2020 · 14 citations · Full text

Medicine, Oncology, Surgery +11